Gaviscon Advance Mint chewable tablets

Land: Vereinigtes Königreich

Sprache: Englisch

Quelle: MHRA (Medicines & Healthcare Products Regulatory Agency)

Wirkstoff:

Potassium bicarbonate; Sodium alginate

Verfügbar ab:

Forum Health Products Ltd

INN (Internationale Bezeichnung):

Potassium bicarbonate; Sodium alginate

Dosierung:

100mg ; 500mg

Darreichungsform:

Chewable tablet

Verabreichungsweg:

Oral

Klasse:

No Controlled Drug Status

Verschreibungstyp:

Valid as a prescribable product

Produktbesonderheiten:

BNF: 01010201; GTIN: 5000158066366

Gebrauchsinformation

4.5 mm
85%
EAN 13
0000000000000
15.0 mm
30 microns
N/A
17.7 mm
BARCODE INFO
Barcode Type:
Barcode Number:
Magnification:
Truncated By:
Full Height:
Bar Height (Smallest Bar):
BWR:
Encoded Data:
Trident Reference No:
ZEN Ref:
Action:
Brand:
Category:
Segment Group:
Segment:
Pack Size:
Market/Country:
Date:
Component Code
(2D if applicable)
:
2
nd
Component Code
(if applicable)
:
Parent Technical Packaging Specification:
Finished Goods Code:
Supply Point:
3rd Party Code
Pharmacode No/NE:
Edgemark Position:
CAD Cam Ref:
Printer:
Substrate:
N/A
N/A
RB Hull
N/A
0000000
Gaviscon
Adult
500mg Tablets
Peppermint
60Tablets
RB451092
Please note that any low resolution paper Canon colour copies
associated with this job should be referred to for content, layout
and colour separation only.
STUDIO USE ONLY
v2.0
Sm•Art check results:
Cutter
Guides
Technical & Non Printing Items
Cutter 2 (if applicable)
Guides 2 (if applicable)
Multi Packaging Solutions (Bourne, UK)
G-Lbl-D0357891-148.3x50mm
TR2063273
PP Top White
UK
17/12/20
B
Muthukumar Rajachithambaram
0000000
N/A
G=2; O=1; R=0; - MR - 17/12/20 11:40:17
RB Artwork and
Print Specification
D0357891
Artwork Type:
BW Submission
10
mm
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
220
230
240
250
1
FLX
PANTONE Reflex Blue C
2
FLX
PANTONE 320 C
3
FLX
PANTONE 185 C
4
FLX
PANTONE Yellow C
5
FLX
Braille
6
FLX
Adhesive_Deadener
7
FLX
Release Varnish
8
FLX
Varnish - High Gloss UV
Colours (Label _Peel Read)
RBH Contact:
Anoop James
Connaught House, Connaught Road,
Kingswood Business Park, Hull, HU7 3AP, England.
T: [phone]
UNDER NO CIRCUMSTANCES SHOULD THIS
ARTWORK BE ALTERED WITHOUT PRIOR
PERMISSION FROM TRIDENT.
GAVISCON
ADVANCE MINT
CHEWABLE
TABLE TS
T B R 1 4 3 0 - D 0 3 5 7 8 9 1 – E n g l i s h
CUSTOMER INFO:
Minimum Point Size =
(Leaflet copy = 9 pt)
7.00pt
0000000
0000000
0000000
0000000
0000000
N/A
0000000
N/A
_60_
_CHEWABLE TABLETS_
GAVISCON IS A TRADE MARK OF THE
RB GROUP OF COMPANIES
PL 00063/0613.
MANUFACTURER AND PRODUCT LICENCE HOL

Fachinformation

OBJECT 1
GAVISCON ADVANCE MINT CHEWABLE
TABLETS
Summary of Product Characteristics Updated 11-Feb-2021 | Forum Health
Products Limited
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Gaviscon Advance Mint Chewable Tablets
2. Qualitative and quantitative composition
Each tablet contains sodium alginate 500 mg and potassium bicarbonate
100 mg.
Excipient(s) with known effect:
Sodium 53.22 mg (2.314 mmol)/tablet
Aspartame (E 951) 4.5 mg/tablet
Potassium 39.43 mg/tablet
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Chewable tablet.
An off-white to cream, circular, flat with bevelled edges tablet with
the odour and flavour of peppermint.
Each tablet is imprinted with a "Sword and Circle" on one side and
"GA500" on the reverse.
4. Clinical particulars
4.1 Therapeutic indications
Treatment of symptoms resulting from the reflux of acid, bile and
pepsin into the oesophagus such as acid
regurgitation, heartburn, indigestion (occurring due to the reflux of